Correlation Between Wave Life and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Wave Life and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wave Life and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wave Life Sciences and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Wave Life and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wave Life with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wave Life and Alnylam Pharmaceuticals.
Diversification Opportunities for Wave Life and Alnylam Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Wave and Alnylam is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Wave Life Sciences and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Wave Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wave Life Sciences are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Wave Life i.e., Wave Life and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Wave Life and Alnylam Pharmaceuticals
Considering the 90-day investment horizon Wave Life Sciences is expected to generate 2.33 times more return on investment than Alnylam Pharmaceuticals. However, Wave Life is 2.33 times more volatile than Alnylam Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 401.00 in Wave Life Sciences on November 3, 2024 and sell it today you would earn a total of 756.00 from holding Wave Life Sciences or generate 188.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Wave Life Sciences vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Wave Life Sciences |
| Alnylam Pharmaceuticals |
Wave Life and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Wave Life and Alnylam Pharmaceuticals
The main advantage of trading using opposite Wave Life and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wave Life position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Wave Life vs. Arrowhead Pharmaceuticals | Wave Life vs. CytomX Therapeutics | Wave Life vs. Assembly Biosciences | Wave Life vs. Apellis Pharmaceuticals |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |